Comparison of Anticoagulants
Apixaban and rivaroxaban are the most commonly used oral anticoagulants for the treatment of acute venous thromboembolism. An international study with a prospective, randomized, open-label, and blinded endpoint design investigated the extent to which the risk of bleeding differs between the two anticoagulants.